Phase 4Not yet recruitingHealthspan endpoint

StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial (SAFEST - RCT)

Sponsor
Prof. dr. Nathalie van der Velde (Academic or other)
Enrollment
612 planned
Conditions
Ischemic Stroke; Transient Ischemic Attack
Interventions
Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin)
Ages
older adults
Registry
NCT06785727

Full record on ClinicalTrials.gov

From the registry

Two Dutch guidelines (Stroke and Cardiovascular Risk Management) provide conflicting advice on optimal statin treatment in older patients. In the SAFEST - RCT, the investigators will assess the impact of starting versus not starting a statin in frail individuals aged 70 and above with a recent ischemic stroke or transient ischemic attack (TIA) on their health-related quality of life and Major Adverse Cardiovascular Events (MACE) free survival during a two-year follow-up period.

Primary outcomes

  • Health-Related Quality of Life (HrQoL)
  • Major Adverse Cardiovascular Events (MACE) free survival

History

  1. Study completion expected

  2. Primary completion expected

  3. Started

  4. Registered

Papers citing this trial